Literature DB >> 24373941

Evaluation of Th17 related cytokines associated with clinical and laboratorial parameters in sickle cell anemia patients with leg ulcers.

Rafael Ramos da Silva1, Michelly Cristiny Pereira1, Moacyr Jesus Barreto Melo Rêgo1, Betania Lucena Domingues Hatzlhofer2, Aderson da Silva Araújo3, Marcos André Cavalcanti Bezerra2, Ivan da Rocha Pitta4, Maira Galdino da Rocha Pitta5.   

Abstract

Leg ulcers (LUs) represent one of the main causes of morbidity in sickle cell anemia (SCA). This manifestation has been related to hemolysis, infections predisposition and inflammation that leads cytokines secretion. In this context, our study aimed to evaluate Th17 related cytokines (IL-6, IL-17A, IL-22 and IL-23) in serum and peripheral mononuclear cells culture supernatants with and without lymphoproliferative stimulation (anti-human CD3 and anti-human CD28). The cytokines levels were also correlated to clinical, hematological and biochemical parameters in SCA patients with and without LUs history (SCALU and SCAWH) as well as in healthy controls. In SCALU patients, high levels of IL-17A were associated with absence of acute chest syndrome (ACS, p=0.0328). The other clinical parameters analyzed (osteonecrosis, stroke, priapism, splenectomy and blood transfusions history) were not significantly related with other cytokine levels. In SCALU patients was also observed that IL-17A increased levels were associated with high levels of LDH (p=0.0130), the same association pattern was found for IL-6 (0.0160) and IL-22 (p=0.0165) in the SCALU group. Interestingly, we did not find statistical correlations with these parameters in SCAWH group. The other hematological parameters (hemoglobin, leucocyte and reticulocyte count) and indirect bilirrubin did not show any correlation with analyzed cytokines in both groups. So, for the first time, we show that IL-17A present in SCALU patients may exert a preventive role in the ACS development. Furthermore, IL-6, IL-17A and IL-22 accompanied the LDH levels only in SCALU patients suggesting to serve as additional markers of hemolysis or to be related with immunity response against extracellular pathogens.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Hemolysis; Inflammation; Leg ulcer; Sickle cell anemia

Mesh:

Substances:

Year:  2013        PMID: 24373941     DOI: 10.1016/j.cyto.2013.11.012

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  4 in total

1.  High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia.

Authors:  Igor F Domingos; Diego A Pereira-Martins; Marcondes J V C Sobreira; Romulo T D Oliveira; Adekunle E Alagbe; Carolina Lanaro; Dulcineia M Albuquerque; Maria H S L Blotta; Aderson S Araujo; Fernando F Costa; Antonio R Lucena-Araujo; Maria F Sonati; Marcos A C Bezerra; Magnun N N Santos
Journal:  Ann Hematol       Date:  2020-03-05       Impact factor: 3.673

2.  Immunological Hallmarks of Inflammatory Status in Vaso-Occlusive Crisis of Sickle Cell Anemia Patients.

Authors:  Alexander Leonardo Silva-Junior; Nadja Pinto Garcia; Evilázio Cunha Cardoso; Stephanny Dias; Andrea Monteiro Tarragô; Nelson Abrahim Fraiji; Matheus Souza Gomes; Laurence Rodrigues Amaral; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho; Erich Vinicius De Paula; Allyson Guimarães Costa; Adriana Malheiro
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

3.  Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitis.

Authors:  Kazumichi Abe; Masashi Fujita; Manabu Hayashi; Atsushi Takahashi; Hiromasa Ohira
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

4.  Treatment of recalcitrant chronic leg ulcer in a known sickle cell anaemia patient using honey and fresh hbaa red cell concentrate in a Nigerian secondary healthcare facility.

Authors:  Marcellinus Uchechukwu Nwagu; Gabriella Ifeoma Omokhua
Journal:  Ann Afr Med       Date:  2020 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.